Novartis AG (LSE:0HKE)
£ 3657.04 0 (0%) Market Cap: 60.95 Bil Enterprise Value: 74.78 Bil PE Ratio: 14.34 PB Ratio: 5.34 GF Score: 77/100

Novartis AG to Discuss Kisqali® MONALEESA-3 ESMO Data Investor Call Transcript

Oct 01, 2019 / 03:30PM GMT
Operator

Good morning and good afternoon, and welcome to the ESMO Data Investor Call. (Operator Instructions) And the conference is being recorded. (Operator Instructions) Recording of the conference call including the Q&A session are available on our website shortly after the call ends. (Operator Instructions)

With that, I would like to hand the call over to Sloan Simpson, U.S. Head, Investor Relations. Please go ahead, Madam.

Sloan Simpson
Novartis AG - Head of IR - North America

Thank you, Summer, and thank you, everyone, for taking the time to join our call today on the Kisqali MONALEESA-3 data presented at ESMO over the weekend. Before we start, I'll just read the safe harbor statement.

The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the company's Form 20-F on file with the U.S.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot